Patents
Patents for C07D 519 - Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups or (11,041)
01/2007
01/02/2007US7157451 Cardiac arrhythmias; potassium channel function inhibitors; such as 7-(3,4-Dichlorophenyl)-6-(5-fluoro-1-methyl-1H-benzimidazol-2-yl)-4,7 -dihydro-5-(methoxymethyl)pyrazolo-(1,5-a)pyrimidine
01/02/2007CA2376668C Naphthyridine derivatives, processes for their preparation, their use and pharmaceutical compositions comprising them
12/2006
12/28/2006US20060293357 Chemical intermediates for indole alkaloids, formed by cyclization of thioanilides, then chlorination of indole derivatives with t-butylhypochlorite, coupling vindolines, deacetylation and desulfonation; anticarcinogrnic agents
12/28/2006US20060293344 Viricide against herpes virus; a pyrazolo[1,5- alpha]pyridinyl compounds; chemical synthesis
12/28/2006US20060292589 Oligonucleotide probes containing two labels useful in hybridization assays
12/28/2006US20060292570 Novel synthetic binding pairs and uses thereof
12/27/2006EP1736476A1 Novel compound and organic electronic device using such compound
12/27/2006EP1483264B1 1-allyl ergot alkaloid derivatives, method for producing the same and the use thereof for preventing and treating migraine
12/27/2006CN1291983C Luminescent element material and luminescent element comprising the same
12/26/2006US7153855 Pyrazolopyridinyl pyrimidine therapeutic compounds
12/21/2006WO2006134378A1 Compounds for the treatment of multi-drug resistant bacterial infections
12/21/2006US20060287379 Derivatives of 3-hydroxy-4-(cyclyl-alkylaminoalkyl)-5-phenyl-1h-pyrazole as antagonists of the gonadotropin releasing hormone (gnrh) for use in the treatment of sex hormone related conditions, such as prostatic of uterine cancer
12/21/2006US20060287308 3-Aminoquinazolin-2,4-dione antibacterial agents
12/21/2006US20060286338 Optical information-recording medium, novel oxonol compound and method of recording information
12/21/2006CA2610900A1 Compounds for the treatment of multi-drug resistant bacterial infections
12/20/2006EP1734040A1 Substituted quinazoline or pyridopyrimidine derivative
12/20/2006EP1733728A2 Use of 2-alkoxyphenyl substituted imidazotriazinones as inhibitors of phosphodiesterase
12/20/2006EP1732552A2 2,6-disubstituted piperidines as modulators of chemokine receptor activity
12/20/2006CN1880319A Tropane derivatives as CCR5 modulators
12/14/2006WO2006131185A1 Monomers , oligomers and polymers of thieno (3, 4-d) thiazole
12/14/2006US20060281781 Preventive and therapeutic medicament for gastroesophageal reflux disease
12/14/2006US20060281736 Product comprising at least one phosphatase cdc25 inhibitor combined with at least one other anticancer agent
12/13/2006EP1731508A1 Weakly basic hindered amines having carbonate skeletons, synthetic resin compositions, and coating compositions
12/13/2006EP1731505A1 Alkoxyphenylpropanoic acid derivatives
12/13/2006EP1730155A1 Thienopyrroles as antagonists of gnrh
12/13/2006EP1730146A1 Azaindoles useful as inhibitors of jak and other protein kinases
12/13/2006EP1294823B1 Double-spiro organic compounds and electroluminescent devices
12/13/2006CN1878774A Method for preparing cucurbiturils
12/13/2006CN1878773A Heteroaryl fused pyridines, pyrazines and pyrimidines as CRF1 receptor ligands
12/12/2006US7148523 Molecular rectifier device
12/12/2006US7148353 For therapy of anxiety and insomnia
12/12/2006US7148214 Antihistaminic spiro compounds
12/07/2006WO2006129626A1 Method for producing [1,2,4]triazolo[1,5-c]pyrimidine derivative
12/07/2006WO2006128920A1 New derivatives of pyrrolyltriazine together with methods for obtaining them and their use as protecting agents against uv radiation
12/07/2006WO2006128791A1 New derivatives of pyrrolyltriazine together with methods for obtaining them and their use as protecting agents against uv radiation
12/07/2006US20060276497 Novel multicyclic compounds and the use thereof
12/07/2006US20060276475 Triazolotriazines and pyrazolotriazines and methods of making and using the same
12/07/2006CA2611134A1 New derivatives of pyrrolyltriazine together with methods for obtaining them and their use as protecting agents against uv radiation
12/06/2006EP1727821A1 Substituted diazabicycloheptanes and their use as protein kinase inhibitors
12/06/2006EP1727817A1 Azabicyclooctan-3-one derivatives and use thereof
12/06/2006EP1270577B1 Furoisoquinoline derivatives, process for producing the same and use thereof
12/05/2006US7144887 Substituted 1,2,3-triazolo[1,5-a]quinazolines for enhancing cognition
12/05/2006US7144691 Oxiranylmethoxyhydrocarbyl-N-oxypiperidine derivatives as stabilizers; blue sensitive silver halide emulsion layer yellow coupler, green sensitive layer contains magenta coupler, and red sensitive layer contains cyan coupler; storage stability
11/2006
11/30/2006WO2006125974A1 Aminopiperidine quinolines and their azaisosteric analogues with antibacterial activity
11/30/2006US20060270661 Pyrrolobenzodiazepines
11/30/2006CA2608072A1 Aminopiperidine quinolines and their azaisosteric analogues with antibacterial activity
11/29/2006EP1726590A1 Cycloalkanopyridine derivative
11/29/2006EP1725564A1 M3 muscarinic acetylcholine receptor antagonists
11/29/2006EP1725558A1 Method for preparing compounds comprising cucurbituril groups
11/29/2006CN1871241A Spirofuropyridine aryl derivatives
11/29/2006CN1871239A Modulation of beta-catenin/tcf-activated transcription
11/28/2006US7141578 For treating cancer, cardiovascular, sexual and immune disorders; 3a alpha ,4 beta ,5 alpha ,7 beta ,7a alpha )-4-(Octahydro-5- ethylsulfonamido-4,7-dimethyl-1,3-dioxo-4,7-epoxy-2H-isoindol-2-yl)-2- (trifluoromethyl)benzonitrile
11/28/2006US7141575 Triazolo[4,5-d]pyrimidine derivatives and their use as purinergic receptor antagonists
11/28/2006US7141571 Anticancer agents; inhibits tyrosine kinase activity of growth factor receptors; antiproliferative agents
11/28/2006US7141565 Substituted quinobenzoxazine analogs
11/28/2006US7141564 are active against a wide range of organisms including both Gram-negative and Gram-positive organisms
11/28/2006CA2234609C 2-amino-6-anilino-purine derivatives and processes for their preparation
11/23/2006WO2006122910A1 Halogenated quindoline dimers for the treatment of cancer
11/23/2006US20060264438 Pyrrolotriazine compounds as kinase inhibitors
11/23/2006US20060264437 Azabicyclylmethyl derivatives of 2,3-dihydro-1,4-dioxino [2,3-F]quinoline as 5-HT1A antagonists
11/22/2006EP1724295A1 Supramolecular complex of pyridylnaphthalenediimide with zinc porphyrin dendrimer having multiplicity of artificial photosynthetic reaction center
11/22/2006EP1724268A1 Compound having tgf-beta inhibitory activity and pharmaceutical composition containing same
11/22/2006EP1724267A1 Pyrimidine derivative
11/22/2006EP1723152A1 Pyrrolobenzodiazepines
11/22/2006EP1723151A2 Pyrrolobenzodiazepines as key intermediates in the synthesis of dimeric cytotoxic pyrrolobenzodiazepines
11/22/2006EP1723150A1 Rifamycin imino derivatives effective against drug-resistant microbes
11/22/2006EP1483265B1 Purine derivatives as kinase inhibitors
11/22/2006EP1051176B1 SUBSTITUTED OXOAZAHETEROCYCLYL FACTOR Xa INHIBITORS
11/22/2006CN1285598C Method for preparing verticillium bacteria A and application
11/21/2006US7138409 Heterocyclic compounds
11/21/2006CA2120619C Novel potent inducers of terminal differentiation and methods of use thereof
11/16/2006US20060258690 Spiro-substituted pyrrologyrimidines
11/15/2006EP1720881A1 11-hydroxy-5h-pyrrolo[2,1-c][1,4]benzodiazepin-5-one derivatives as key intermediates for the preparation of c2 substituted pyrrolobenzodiazepins
11/15/2006EP1720880A1 C8, c8' linked 5-oxo-1,2,3,11a-tetrahydro-5h-pyrrolo[2,1-c][1,4]benzodiazepine dimers with 1h-pyrrole-dicarboxylic acid amide linkers and oligomeric analogs thereof as well as related compounds for the treatment of proliferative diseases
11/15/2006CN1863890A New compound capable of being used in organic layer of organic light emitting device
11/15/2006CN1863805A Disulfide, sulfide, sulfoxide, and sulfone derivatives of cyclic sugars and uses thereof
11/09/2006WO2006118341A1 Novel lactam compound
11/09/2006WO2006117670A1 2-amido-6-amino-8-oxopurine derivatives as toll-like receptor modulators for the treatment of cancer and viral infections, such as hepatitis c
11/09/2006US20060252760 Farnesyl transferase inhibitors
11/09/2006US20060252730 Adenosine receptor antagonists and methods of making and using the same
11/09/2006CA2607780A1 Purine derivatives
11/09/2006CA2607506A1 Novel lactam compound
11/08/2006EP1604021A4 Methods for identifying enzyme inhibitors and protein kinases
11/07/2006US7132439 Bis-benzimidazoles and related compounds as potassium channel modulators
11/07/2006US7132116 Compositions and methods for the treatment of primary and metastatic neoplastic diseases using arsenic compounds
11/07/2006CA2131680C Process for preparing imidazopyridine derivatives
11/02/2006WO2006114606A1 Fused thiazole derivatives as kinase inhibitors
11/02/2006US20060247251 2-Cyanopyrrolopyrimidines and pharmaceutical uses thereof
11/02/2006US20060247245 Substituted imidazolopyrazine and triazolopyrazine derivatives: gabaa receptor ligands
11/02/2006CA2607426A1 Fused thiazole derivatives as kinase inhibitors
11/01/2006CN1856495A Imidazopyridine-derivatives as inducible NO-synthase inhibitors
11/01/2006CN1854143A Production of catharanthine compound and its medicinal salt
10/2006
10/31/2006US7129249 Heterocyclic amide derivatives as inhibitors of glycogen phoshorylase
10/31/2006US7129239 Dietetics; cardiovascular disorders; strokes; antidiabetic agents, sleep disorders, osteoporosis
10/26/2006WO2006111759A1 Pyrrolobenzodiazepines
10/26/2006US20060241127 N-[2-Amino-6-(4-pyridinyl)-4-pyrimidinyl]-N-[2-fluoro-4-(1H-pyrrolo[2,3-b]-pyridin-4-yloxy)phenyl]amine, used for the treatment and/or prophylaxis of cardiovascular diseases and erectile dysfunction
10/26/2006US20060241120 Cannabinoid Receptor Ligands and Uses Thereof
10/26/2006CA2604805A1 Pyrrolobenzodiazepines
10/25/2006EP1715019A1 Single-layer organic el device
10/25/2006EP1713809A1 Dimeric azacyclic compounds and their use
1 ... 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 ... 111